PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

AIM-HI Accelerator Fund celebrates Yiviva's milestone collaboration with AstraZeneca China, furthering technology platforms for multiple cancers

AIM-HI Accelerator Fund celebrates Yiviva's milestone collaboration with AstraZeneca China, furthering technology platforms for multiple cancers
2024-02-07
(Press-News.org) Accelerating Innovation in Medicine - Health Initiative (AIM-HI) is proud to celebrate a significant milestone in the journey of one of its esteemed portfolio companies, Yiviva. A clinical-stage platform biotechnology company, Yiviva has entered into a Memorandum of Understanding (MOU) with AstraZeneca China, a multinational biopharmaceutical leader.

AIM-HI exists to support bold new ideas in treating and preventing cancer. So when Yale Professor Yung-Chi Cheng approached us years ago about mining ancient Chinese herbs for modern therapies, we took notice. Other investors saw risk. We saw possibility. We decided to provide early capital to progress Dr. Cheng’s vision of a new biotech fusion calling “WE Medicine” -  integrating Eastern traditional medicine and Western clinical science. Our funding helped launch Yiviva to develop their plant-based formulas into cancer-fighting drug candidates.

Over the next four years, AIM-HI continued nurturing this startup’s growth with additional financing of more than $600,000 between 2018 and 2020, empowering the company to pursue innovative research initiatives focused on multiple cancers and proceeding with human trials. Meanwhile, our advisors guided Yiviva’s management team on executing its unique clinical strategy.

Yiviva advanced its lead compound YIV-906 into human trials showing early signs it could amplify other cancer therapies’ effects. Now studying YIV-906 across phase II trials in liver, pancreatic and other cancers, results suggest it stimulates anti-tumor immunity while protecting normal tissue. Beyond YIV-906, Yiviva’s pipeline contains multiple other botanical extracts undergoing preclinical analysis or early-phase testing as possible additions to standard chemotherapy, immunotherapy and radiation regimens.

AIM-HI’s sustained involvement is paying dividends. Yiviva recently inked a major partnership with pharmaceutical leader AstraZeneca to tap into its state-of-the-art facilities in China. This partnership designates global recognition of Yiviva’s pioneering work extracting and enhancing natural cancer-combating compounds.

For AIM-HI, this progress for Yiviva represents the realization of our mission to accelerate translation of new concepts from lab to patients. Yiviva's focus on developing innovative medicines for cancer, aligns with AIM-HI's vision of advancing breakthroughs in cancer research and bringing transformative therapies to patients globally. The collaboration with AstraZeneca China is expected to further Yiviva's technology platforms, ultimately benefiting patients with a range of cancers.

"The collaboration between Yiviva and AstraZeneca is a significant milestone for AIM-HI and our commitment to advancing breakthrough discoveries in cancer research. Yiviva's progress exemplifies the potential of strategic investments in propelling our portfolio companies towards multinational collaborations," said Dr. Sujuan Ba, Presient and CEO of AIM-HI Accelerator Fund.

Peikwen Cheng, CEO of Yiviva, expressed gratitude for AIM-HI's support, stating, "AIM-HI's strategic investment has been crucial in advancing our research initiatives. Today's collaboration with AstraZeneca China signifies a new chapter in our journey, and we are excited about the potential impact on cancer treatment globally."

 

About AIM-HI:

AIM-HI, the Accelerating Innovation in Medicine - Health Initiative, is a non-profit organization dedicated to advancing breakthrough discoveries in cancer research and accelerating their translation to the clinic. AIM-HI supports strategic investments in portfolio companies with the potential to revolutionize cancer treatment. For more information, please visit www.aim-hiaccelerator.org

END

[Attachments] See images for this press release:
AIM-HI Accelerator Fund celebrates Yiviva's milestone collaboration with AstraZeneca China, furthering technology platforms for multiple cancers AIM-HI Accelerator Fund celebrates Yiviva's milestone collaboration with AstraZeneca China, furthering technology platforms for multiple cancers 2

ELSE PRESS RELEASES FROM THIS DATE:

New scientific research will test PREVENT risk calculator among diverse groups

2024-02-07
DALLAS, Feb. 7, 2024 — Research teams from Northwestern University Feinberg School of Medicine, New York University and Duke University will work together to assess the accuracy of the American Heart Association’s new PREVENTTM risk calculator with funding from the Association’s De-biasing Clinical Care Algorithms project. The American Heart Association, celebrating 100 years of service in 2024, is­ the single largest non-government supporter of heart and brain health research in the U.S. The de-biasing project is funded by a grant from the Doris Duke Foundation to study the role of race and ethnicity in clinical equations and their ...

Does your community have a personality type?

Does your community have a personality type?
2024-02-07
Geographic sorting along ideological lines is on the rise. Counties and regions of the United States differ in political ideology. But do they differ in personality as well? Further, are people who ‘fit’ their communities healthier, happier, or more highly achieving than those who do not? In the context of these growing divisions and to address this question, a study by Florida Atlantic University’s Kevin Lanning, Ph.D., senior author and a professor of psychology and data science in the Harriet L. Wilkes Honors College on FAU’s John D. MacArthur Campus in Jupiter, and ...

MXene-coated devices can guide microwaves in space and lighten the payload

MXene-coated devices can guide microwaves in space and lighten the payload
2024-02-07
One of the most important components of satellites that enable telecommunication is the waveguide, which is a metal tube for guiding radio waves. It is also one of the heaviest payloads satellites carry into orbit. As with all space technology, reducing weight means reducing the amount of expensive and greenhouse gas-producing fuel it takes to launch a rocket, or increasing the number of devices carried by the same rocket to space. Researchers from Drexel University and the University of British Columbia are trying to lighten the load by creating and testing a waveguide made ...

Daily intake of tree nuts, including pistachios, does not lead to weight gain, body fat gain, or changes in energy intake in Millennials

Daily intake of tree nuts, including pistachios, does not lead to weight gain, body fat gain, or changes in energy intake in Millennials
2024-02-07
More than half of Americans do not currently meet the daily recommendation of 5–7 ounce equivalents^ of nuts and seeds per week.1 One possible contributor to such low intakes of tree nuts could be a fear that the calories or fat composition of tree nuts leads to weight gain. For example, past studies suggest that up to 87% of Americans think eating nuts can lead to weight gain due to their dietary fat content2 despite scientists confirming that eating nuts every day, including pistachios,3 can be an achievable and simple strategy to ...

New method to more accurately spot underground nuclear tests

2024-02-07
A more accurate way of identifying underground nuclear tests, including those conducted in secret, has been developed by researchers at The Australian National University (ANU).   The new method could help international observers better identify tests carried out by countries or actors known to possess nuclear weapons, as well as providing new information about those suspected of being armed.   According to lead author Dr Mark Hoggard, in the aftermath of the Cuban Missile Crisis and Partial Test Ban Treaty in the 1960s, testing of nuclear ...

More than half million dollars in research grants awarded to understand No. 1 birth defect

2024-02-07
DALLAS, Feb. 6, 2024 — Five promising scientific researchers will advance their work to better understand and treat the most common birth defect in the U.S., congenital heart defects (CHDs), thanks to joint financial support from the American Heart Association and The Children’s Heart Foundation's Congenital Heart Defect Research Awards program. To date, the American Heart Association, celebrating 100 years of lifesaving service and devoted to a world of healthier lives for all, and The Children’s Heart Foundation, dedicated to funding congenital heart defect research, have ...

Rice’s Santiago Segarra wins NSF CAREER Award

Rice’s Santiago Segarra wins NSF CAREER Award
2024-02-07
HOUSTON – (Feb. 7, 2024) – Artificial intelligence is good at many tasks involving data in the form of text, audio and images, including face recognition and text summarization. “AI is an amazing tool and has been extended over less conventional domains, such as climate data defined on spheres (representing the Earth) and traffic data defined on road networks,” said Santiago Segarra, assistant professor of electrical and computer engineering and statistics. With his five-year, $599,138 CAREER Award from the National Science Foundation, Segarra intends to study the use of graphs to represent these ...

Music may bring health benefits for older adults, poll suggests

Music may bring health benefits for older adults, poll suggests
2024-02-07
Whether it’s singing in a choir, playing the living room piano, joining in hymns at church, or just whistling along with the radio, a new poll finds that nearly all older adults say music brings them far more than just entertainment. Three-quarters of people age 50 to 80 say music helps them relieve stress or relax and 65% say it helps their mental health or mood, according to the new results from the University of Michigan National Poll on Healthy Aging. Meanwhile, 60% say they get energized or motivated ...

From waste to resource: A new and sustainable process transforms sewage sludge into activated carbon

From waste to resource: A new and sustainable process transforms sewage sludge into activated carbon
2024-02-07
Sewage sludge is the solid waste resulting from wastewater treatment. According to data from the Ministry for the Ecological Transition and the Demographic Challenge, 1.2 million tons of this waste were produced in Spain in 2021 alone, and its management is a growing problem. Although some of it may have agricultural applications, such as being used as fertilizer after composting, its high concentration of metals limits its use, generating environmental problems. A new study has managed to give this waste a second life, turning it into activated carbon, a product boasting ...

Incheon National University researcher examines proactive change-oriented behaviors by public service providers

Incheon National University researcher examines proactive change-oriented behaviors by public service providers
2024-02-07
Although change-oriented behaviors are critical to high quality public service delivery, encouraging employees to embrace and pursue change in the public sector is difficult. Even with sufficient job autonomy–the principal antidote to resistance to change in the public sector literature–public servants may still lack the incentives, skills, information, and sense of security necessary to engage in proactive change-oriented behavior. Consequently, while job autonomy is undoubtedly important, it alone is not enough, as demonstrated by the many cases in which autonomy fails to lead to change and work process improvements. Given the importance of attitudes ...

LAST 30 PRESS RELEASES:

New switch for programmed cell death identified

Orcas seen killing young great white sharks by flipping them upside-down

ETRI achieves feat of having its technology adopted as Brazil’s broadcasting standard

Agricultural practices play a decisive role in the preservation or degradation of protected areas

Longer distances to family physician has negative effect on access to health care

Caution advised with corporate virtual care partnerships

Keeping pediatrics afloat in a sea of funding cuts

Giant resistivity reduction in thin film a key step towards next-gen electronics for AI

First pregnancy with AI-guided sperm recovery method developed at Columbia

Global study reveals how bacteria shape the health of lakes and reservoirs

Biochar reimagined: Scientists unlock record-breaking strength in wood-derived carbon

Synthesis of seven quebracho indole alkaloids using "antenna ligands" in 7-10 steps, including three first-ever asymmetric syntheses

BioOne and Max Planck Society sign 3-year agreement to include subscribe to open pilot

How the arts and science can jointly protect nature

Student's unexpected rise as a researcher leads to critical new insights into HPV

Ominous false alarm in the kidney

MSK Research Highlights, October 31, 2025

Lisbon to host world’s largest conference on ecosystem restoration in 2027, led by researcher from the Faculty of Sciences, University of Lisbon

Electrocatalysis with dual functionality – an overview

Scripps Research awarded $6.9 million by NIH to crack the code of lasting HIV vaccine protection

New post-hoc analysis shows patients whose clinicians had access to GeneSight results for depression treatment are more likely to feel better sooner

First transplant in pigs of modified porcine kidneys with human renal organoids

Reinforcement learning and blockchain: new strategies to secure the Internet of Medical Things

Autograph: A higher-accuracy and faster framework for compute-intensive programs

Expansion microscopy helps chart the planktonic universe

Small bat hunts like lions – only better

As Medicaid work requirements loom, U-M study finds links between coverage, better health and higher employment

Manifestations of structural racism and inequities in cardiovascular health across US neighborhoods

Prescribing trends of glucagon-like peptide 1 receptor agonists for type 2 diabetes or obesity

Continuous glucose monitoring frequency and glycemic control in people with type 2 diabetes

[Press-News.org] AIM-HI Accelerator Fund celebrates Yiviva's milestone collaboration with AstraZeneca China, furthering technology platforms for multiple cancers